Search
01/02/2026
Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease
Llena-Meler, M, Canfran-Duque, A, Madrigal-Matute, J, Rotllan, N. Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. SEMINARS IN CANCER BIOLOGY. 2026; 119DOI:10.1016/j.semcancer.2026.01.003. PMID:41520912. IF:15.700(Q1/1D).
01/02/2026
Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort
Téllez, L, Donate, J, Guerrero, A, Beraza, IA, San Martín, D, Alvarado, E, Echevarria, V, Puente, A, Zamora, J, Del Prado, S, Tenes, A, Balagué, G, Vidal, B, Geli, C, Rodriguez-Gandia, MA, Baiges, A, Brujats, A, Rodríguez, DLH, Sánchez, SFG, Fortea, JI, del Cerro, MJ, Villanueva, C, Garcia-Pagán, JC, Giráldez, A, Albillos, A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort. JOURNAL OF HEPATOLOGY. 2026; 84(2)DOI:10.1016/j.jhep.2025.09.011. PMID:41076090. IF:33.000(Q1/1D).
01/02/2026
Predictors of early immunosuppression at ulcerative colitis onset in the biological era
Piñero, G, Castillo, E, González-Muñoza, C, Calm, A, Pujol, C, Gordillo, J, Calafat, M, Bertoletti, F, Garcia-Planella, E, Mañosa, M, Domènech, E. Predictors of early immunosuppression at ulcerative colitis onset in the biological era. Gastroenterologia y Hepatologia. 2026; 49(2)DOI:10.1016/j.gastrohep.2025.502533. PMID:40680924. IF:1.900(Q3/7D).
01/02/2026
Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study
Pérez, MAC, Grillo, S, Rombauts, A, Martinez, MAR, Falcó-Roget, A, Albasanz-Puig, A, Viñado-Pérez, B, Fernández-Hidalgo, N, Camps-Relats, L, Bergas, A, Laporte-Amargos, J, López-Contreras, J, Escolà-Vergé, L. Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2026; 67(2)DOI:10.1016/j.ijantimicag.2025.107706. PMID:41456670. IF:4.600(Q1/2D).